ACE2 naturally protects against acute lung injury [56], which explains the increased lung pathophysiology and pathobiology (e.g., acute respiratory distress syndrome, pneumonia, and lung injury) due to dysregulation of ACE2 resulting from binding to the spike protein of SARS-CoV-2 [57]. The gene discussed is ACE2; the disease is susceptibility to pneumonia measurement.